By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Onyx Pharmaceuticals, Inc. 

249 E. Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-266-0000 Fax: 650-266-0100


SEARCH JOBS

About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com. Onyx Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed @OnyxPharm at http://twitter.com/OnyxPharm.


Key Statistics


Email:
Ownership: Public

Web Site: Onyx
Employees: 900
Symbol: AMGN
 



Industry
Biotechnology






Company News
Medtronic (MDT) Initiates Pivotal Studies Of Resolute Onyx (AMGN) Drug-Eluting Stent In United States 3/12/2015 9:22:17 AM
Fate Unknown for Remaining 200 Onyx (AMGN) Employees; Will They Head to Washington State? 3/12/2015 12:58:15 AM
The Reason Why Onyx (AMGN)'s Experiment To Become The Next Genentech (RHHBY) Failed 3/11/2015 2:59:37 PM
Amgen (AMGN) Will Shutter SSF Onyx (AMGN) Site, Lay Off At Least 300 3/10/2015 3:22:34 PM
Why Ex-Onyx (ONXX) CEO And Big Pharma Are Taking On Brain Diseases 2/13/2015 7:39:05 AM
Ex-Onyx Pharmaceuticals, Inc. (ONXX) CEO Leads MA Biotech Startup 12/15/2014 6:06:25 AM
Amgen (AMGN) And Onyx Pharmaceuticals, Inc. (ONXX) Announce Detailed Results From Phase 3 ASPIRE Study Of KyprolisĀ® (Carfilzomib) In Patients With Relapsed Multiple Myeloma 12/8/2014 6:12:14 AM
Amgen (AMGN) And Onyx Pharmaceuticals, Inc. (ONXX) Data At American Society of Clinical Oncology 2014 Highlight Oncology Pipeline And Portfolio 5/28/2014 6:23:06 AM
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Misses Target In Phase 3 Liver Cancer Trial 3/11/2014 6:25:33 AM
Ligand Pharmaceuticals Inc. (LGND) To Receive $1 Million Kyprolis® Commercial Milestone Payment From Onyx Pharmaceuticals, Inc. (ONXX) 2/11/2014 8:48:15 AM
12345678910...
//-->